4SC AG | Income Statement

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
4,904.00
7,055.00
2,296.00
2,060.00
4,197.00
4,173
Cost of Goods Sold (COGS) incl. D&A
2,549.00
5,098.00
1,935.00
899.00
1,404.00
1,184
Gross Income
2,355.00
1,957.00
361.00
1,161.00
2,793.00
2,989
SG&A Expense
12,263.00
11,452.00
8,460.00
13,568.00
13,788.00
20,546
EBIT
9,908.00
9,495.00
-
12,407.00
10,995.00
17,557
Unusual Expense
710.00
2.00
31.00
31.00
7.00
-
Non Operating Income/Expense
21.00
53.00
124.00
589.00
61.00
8
Interest Expense
-
228.00
322.00
-
-
-
Pretax Income
10,544.00
9,665.00
8,246.00
11,806.00
10,927.00
17,565
Income Tax
-
70.00
40.00
71.00
33.00
94
Equity in Affiliates
19.00
39.00
58.00
522.00
-
-
Consolidated Net Income
10,525.00
9,696.00
8,228.00
11,355.00
10,960.00
17,659
Net Income
10,525.00
9,696.00
8,228.00
11,355.00
10,960.00
17,659
Net Income After Extraordinaries
10,525.00
9,696.00
7,228.00
11,544.00
10,960.00
17,659
Net Income Available to Common
10,525.00
9,696.00
9,228.00
11,166.00
10,960.00
17,659
EPS (Basic)
0.98
0.89
0.63
0.58
0.45
0.55
Basic Shares Outstanding
10,742.50
10,800.10
14,473.50
19,138.30
24,535.50
32,128.90
EPS (Diluted)
0.98
0.90
0.64
0.58
0.45
0.55
Diluted Shares Outstanding
10,742.50
10,800.10
14,473.50
19,138.30
24,535.50
32,128.90
EBITDA
8,753.00
8,400.00
7,204.00
11,515.00
10,096.00
16,716
Non-Operating Interest Income
53.00
3.00
20.00
43.00
14.00
-

About 4SC

View Profile
Address
Fraunhoferstrasse 22
Planegg-Martinsried Bayern (Bavaria) 82152
Germany
Employees -
Website http://www.4sc.de
Updated 07/08/2019
4SC AG engages in the development of small molecule drugs that targets cancer through epigenetic mechanisms. It also involves in the preclinical and clinical development of its products. Its assets are resminostat, 4SC-202, and 4SC-208.